RGX-314

· AbbVie

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for RGX-314, covering 2023-05-16 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: Pivotal 2 Study of RGX-314 Gene Therapy in Participants With nAMD [Phase 3]